KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adient (ADNT) Total Current Liabilities (2016 - 2025)

Adient (ADNT) has disclosed Total Current Liabilities for 10 consecutive years, with $3.7 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities changed 0.24% year-over-year to $3.7 billion, compared with a TTM value of $3.7 billion through Sep 2025, changed 0.24%, and an annual FY2025 reading of $3.7 billion, changed 0.24% over the prior year.
  • Total Current Liabilities was $3.7 billion for Q3 2025 at Adient, up from $3.6 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $3.7 billion in Q3 2023 and bottomed at $3.4 billion in Q2 2022.
  • Average Total Current Liabilities over 5 years is $3.6 billion, with a median of $3.6 billion recorded in 2025.
  • Peak annual rise in Total Current Liabilities hit 17.77% in 2021, while the deepest fall reached 13.31% in 2021.
  • Year by year, Total Current Liabilities stood at $3.5 billion in 2021, then fell by 2.65% to $3.4 billion in 2022, then increased by 3.8% to $3.5 billion in 2023, then grew by 3.66% to $3.7 billion in 2024, then rose by 0.24% to $3.7 billion in 2025.
  • Business Quant data shows Total Current Liabilities for ADNT at $3.7 billion in Q3 2025, $3.6 billion in Q2 2025, and $3.5 billion in Q1 2025.